Literature DB >> 28719321

Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease.

Poopak Farnia1,2, Jalaledin Ghanavi2, Shima Saif2, Parissa Farnia2, Ali Akbar Velayati2.   

Abstract

Nontuberculous mycobacteria (NTM) cause significant pulmonary infections in humans. Researchers have reported an association between interferon-gamma receptor-1 (IFN-γR1 or IFNGR1) deficiency and susceptibility to NTM, but the relevance of polymorphism within these genes is not yet clear. In this study, a single nucleotide polymorphism (SNP), T to C, at position-56 in NTM patients with pulmonary disease was investigated. Molecular identification of Mycobacterium isolates was performed with hsp65 genes using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Then, the host genomic DNA from confirmed NTM patients (N = 80) and control subjects (N = 80) were screened for SNPs of IFNGR1 (T-56C) by PCR-RFLP. The results indicated that NTM patients had higher TC (26/80; 32.5%) or CC (46/80; 57.5%) genotypes in comparison with control groups (TC genotypes [22/80, 27.5%]; CC genotypes [6/80, 7.5%]) (P < 0.05). In this regard, all the patients infected with rapid-growing Mycobacterium (RGM, i.e., Mycobacterium chelonae and Mycobacterium fortuitum) had CC genotypes (100%). In contrary, only 50.7% (35/69) of infected patients with slow-growing Mycobacterium (i.e., Mycobacterium simiae, Mycobacterium kansasii, and Mycobacterium avium-intracellulare) had CC genotypes. Thus, patients with CC mutation in IFNGR1 at position-56 are more likely to develop RGM infection. In overall, there is a significant association between SNP of IFNGR1 at position-56 and susceptibility to NTM infection. Based on these data, we propose SNP of IFNGR1 at position-56 as a suitable "biomarker" for identifying populations at higher risk of infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28719321      PMCID: PMC5508906          DOI: 10.4269/ajtmh.16-0905

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

Review 1.  Susceptibility to mycobacterial infections: the importance of host genetics.

Authors:  R Bellamy
Journal:  Genes Immun       Date:  2003-01       Impact factor: 2.676

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 3.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.

Authors:  M J Newport; C M Huxley; S Huston; C M Hawrylowicz; B A Oostra; R Williamson; M Levin
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

Review 6.  Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.

Authors:  S Dupuis; R Döffinger; C Picard; C Fieschi; F Altare; E Jouanguy; L Abel; J L Casanova
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

Review 7.  Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment.

Authors:  J O Falkinham
Journal:  J Appl Microbiol       Date:  2009-02-18       Impact factor: 3.772

8.  Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.

Authors:  Thorsten Thye; Gerd D Burchard; Manfred Nilius; Bertram Müller-Myhsok; Rolf D Horstmann
Journal:  Am J Hum Genet       Date:  2003-01-06       Impact factor: 11.025

Review 9.  The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 10.  '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors:  M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

View more
  2 in total

1.  The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients.

Authors:  Changguo Chen; Lei Chen; Changwei Chen; Qiuyuan Chen; Qiangyuan Zhao; Youyou Dong
Journal:  Dis Markers       Date:  2017-10-25       Impact factor: 3.434

2.  A gene variation of Interferon Gamma Receptor-I promoter (rs1327474A>G) and chronic hepatitis C virus infection.

Authors:  Maryam Karkhane; Seyed Reza Mohebbi; Afsaneh Sharifian; Amir Ghaemi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.